Warfarin dosing by genotype did not improve time in therapeutic range

被引：0
|
作者：
Dunn, Andrew [1 ]
机构：
[1] Mt Sinai Hlth Syst, New York, NY 10029 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2014年 / 160卷 / 06期
关键词：
PHARMACOGENETICS; POLYMORPHISMS; INITIATION; CYP2C9; TRIAL;
D O I：
10.7326/0003-4819-160-6-201403180-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Pharmacist’s interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial
    Slaven Falamić
    Marko Lucijanić
    Maja Ortner Hadžiabdić
    Srećko Marušić
    Vesna Bačić Vrca
    International Journal of Clinical Pharmacy, 2018, 40 : 1078 - 1085
  • [22] Pharmacist's interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial
    Falamic, Slaven
    Lucijanic, Marko
    Hadziabdic, Maja Ortner
    Marusic, Srecko
    Vrca, Vesna Bacic
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (05) : 1078 - 1085
  • [23] Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study
    Kim, Y. -K.
    Nieuwlaat, R.
    Connolly, S. J.
    Schulman, S.
    Meijer, K.
    Raju, N.
    Kaatz, S.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) : 101 - 106
  • [24] The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
    Celik, Ahmet
    Izci, Servet
    Kobat, Mehmet Ali
    Ates, Ahmet Hakan
    Cakmak, Abdulkadir
    Cakilli, Yasin
    Yilmaz, Mehmet Birhan
    Zoghi, Mehdi
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (08): : 595 - 600
  • [25] Warfarin therapeutic monitoring: is 70% time in the therapeutic range the best we can do?
    Lader, E.
    Martin, N.
    Cohen, G.
    Meyer, M.
    Reiter, P.
    Dimova, A.
    Parikh, D.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (04) : 375 - 377
  • [26] Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial
    Marcatto, Leiliane Rodrigues
    Sacilotto, Luciana
    Bueno, Carolina Tosin
    Facin, Mirella
    Cassaro Strunz, Celia Maria
    Costa Darrieux, Francisco Carlos
    Scanavacca, Mauricio Ibrahim
    Krieger, Jose Eduardo
    Pereira, Alexandre Costa
    Junior Lima Santos, Paulo Caleb
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [27] Identification of environmental and genetic factors that influence warfarin time in therapeutic range
    Botton, Mariana R.
    Viola, Patricia P.
    Meireles, Mariana R.
    Bruxel, Estela M.
    Zuchinali, Priccila
    Bandinelli, Eliane
    Rohde, Luis E.
    Leiria, Tiago L. L.
    Salamoni, Joyce Y. Y.
    Garbin, Arthur P.
    Hutz, Mara H.
    GENETICS AND MOLECULAR BIOLOGY, 2020, 43 (01)
  • [28] The Association of Health Literacy With Time in Therapeutic Range for Patients on Warfarin Therapy
    Oramasionwu, Christine U.
    Bailey, Stacy Cooper
    Duffey, Kristin E.
    Shilliday, Betsy Bryant
    Brown, Lori C.
    Denslow, Sheri A.
    Michalets, Elizabeth Landrum
    JOURNAL OF HEALTH COMMUNICATION, 2014, 19 : 19 - 28
  • [29] Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range – study protocol for a randomized controlled trial
    Leiliane Rodrigues Marcatto
    Luciana Sacilotto
    Carolina Tosin Bueno
    Mirella Facin
    Celia Maria Cassaro Strunz
    Francisco Carlos Costa Darrieux
    Maurício Ibrahim Scanavacca
    Jose Eduardo Krieger
    Alexandre Costa Pereira
    Paulo Caleb Junior Lima Santos
    BMC Cardiovascular Disorders, 16
  • [30] Determination of Factors Affecting Time in Therapeutic Range in Patients on Warfarin Therapy
    Turen, Sevda
    Turen, Selahattin
    BIOLOGICAL RESEARCH FOR NURSING, 2023, 25 (01) : 170 - 178
12345